Acadian Asset Management LLC Lian Bio Transaction History

Acadian Asset Management LLC

  • $28.7 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$1.33 - $4.6 $221,496 - $766,079
-166,539 Reduced 91.94%
14,605 $65,000
Q3 2023

Nov 13, 2023
BUY
$1.49 - $2.46 $57,823 - $95,467
38,808 Added 27.27%
181,144 $268,000
Q2 2023

Aug 07, 2023
BUY
$1.79 - $2.85 $254,781 - $405,657
142,336 New
142,336 $323,000

Others Institutions Holding LIAN

# of Institutions
4
Shares Held
1.09M
Call Options Held
0
Put Options Held
0
View Full List

About LianBio

LIAN Quotes by TradingView
  • Ticker LIAN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,354,000
  • Market Cap $33.6M
  • Description
  • LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...
More about LIAN
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email